title: Risk associated HIV-1 cross-clade resistance of whole peripheral blood mononuclear cells from exposed uninfected individuals with wild-type CCR5.
abstract: Highly HIV exposed, persistently uninfected individuals (EUs) may hold clues to the generation of effective vaccine induced acquired immunity against HIV, and considerable effort has been devoted to detecting and characterizing HIV specific immune responses in EU cohorts. When searching for such clues, it is important to exclude individuals with genetically determined absence of receptors, as this protective mechanism could not be induced by HIV specific vaccines. Homozygosity for the DeltaC32 mutation of CCR5 prevents R5 HIV infection, independent of any virus-specific immune responses that may be acquired by exposure, while heterozygosity influences susceptibility to low level exposure. Reports on the in vitro susceptibility of EU cells compared to controls have been conflicting. Therefore, we studied 14 EUs with homozygous wild type CCR5, using a newly developed in vitro challenge assay (IVCA) to measure the magnitude and breadth of resistance to infection among EUs. CD8+ cells were relatively increased compared to controls, and were largely responsible for resistance to challenge, which depended on dose of virus inoculum, and extended across clades. Consistent with some EU cohort studies, resistance waned among individuals who reduced their high-risk behavior.
authors.affiliation: Department of Pathology, Rush-Presbyterian St. Luke's Medical Center, Chicago, IL, USA.
authors.forename: Rohan
authors.initials: R
authors.lastname: John
authors.forename: Silvio
authors.initials: S
authors.lastname: Arango-Jaramillo
authors.forename: Gnanadurai J
authors.initials: GJ
authors.lastname: Finny
authors.forename: David H
authors.initials: DH
authors.lastname: Schwartz
mesh_terms: D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D018925:Chemokines / Q000378:metabolism; D015331:Cohort Studies; D003429:Cross Reactions; D018023:HIV Seronegativity / Q000235:genetics / Q000276:immunology*; D015497:HIV-1 / Q000235:genetics* / Q000276:immunology*; D006720:Homozygote; D006801:Humans; D007113:Immunity, Innate / Q000276:immunology; D066298:In Vitro Techniques; D007963:Leukocytes, Mononuclear / Q000276:immunology*; D019713:Receptors, CCR5 / Q000235:genetics*; D012309:Risk-Taking
chemical_list: D018925:Chemokines; D019713:Receptors, CCR5